Cytologic changes in two cervical carcinoma cell lines after transfection of the wild-type p53 gene

Acta Obstetricia et Gynecologica Scandinavica

Volumn 75, Issue 9, 1996, Pages 797-803

  Iwasaka, Tsuyoshi ^a   Zheng, Peng Sheng ^a   Ouchida, Mamoru ^a   Yamasaki, Humio ^a   Yokoyama, Masatoshi ^a   Sugimori, Hajime ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Cervical carcinoma; Cytologic change; M phase arrest; Transfection; Wild type p53 gene

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LINE; CELL SHAPE; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; GENETIC TRANSFECTION; GIANT CELL; HUMAN; HUMAN CELL; PAPANICOLAOU TEST; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA;

EID: 0029808935     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349609054706     Document Type: Article

References (28)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
2. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
3. Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 1990; 10; 5772-81.
4. Velu T. Involvement of the p53 tumor suppressor gene in Ph1-positive and Ph1-negative myeloid leukemia. Blood 1990; 76: 1893-4.
5. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A. Kinzler KW, Fogelstein B. Oncogenic forms of p53 inhibit p53- regulated gene expression. Science 1992; 256: 827-30.
6. Ginsberg D, Mechta F, Yaniv M, Oren M. Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 1991; 88: 9979-83.
7. Santhanam U, Ray A, Sehgal PB. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 1991; 88: 7605-9.
8. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-45.
9. Howley PM. Role of human papillomaviruses in human cancer. Cancer Res 1991; 51: 5019s-22s.
10. Vousden K. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. The FASEB Journal 1993; 7: 872-9.
11. Crook T, Wrede D, Vousden KH. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 1991; 6: 873-5.
12. Scheffner M, Munger K, Byrne JC, Howley PM. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991; 88: 5523-7.
13. Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K et al. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Gynecol Oncol 1993; 48: 104-9.
14. Mercer WE, Shield MT, Amin M, Sauve GJ, Appella E, Romano JW et al. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990; 87: 6166-70.
15. Casey G, Lo Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 1991; 6: 1791-7.
16. Shaw P, Bovey R, Tardy S, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495-9.
17. Cheng J, Yee JK, Yeargin J, Friedmann T, Haas M. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. Cancer Res 1992; 52: 222-6.
18. Zheng PS, Iwasaka T, Ouchida M, Fukuda K, Yokoyama M, Sugimori H. Growth suppression of a cervical cancer cell line (TMCC-1) by the human wild type p53 gene. Gynecol Oncol 1996; 60: 245-50.
19. Sykes JA, Whitescarver J, Jernstrom P, Nolan JF, Byatt P. Some properties of a new epithelial cell line of human origin. JNCI 1970; 45: 107-22.
20. Reuter S, Delius H, Kahn T, Hofmann B, zur Hausen H, Schwarz E. Characteristics of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol 1991; 65: 5564-8.
21. Ginsberg D, Michalovitz DM, Oren M. Introduction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol Cell Biol 1991; 11: 582-5.
22. Oren M. p53: the ultimate tumor suppressor gene. The FASEB J 1992; 6: 3169-76.
23. Ryan JJ, Danish R, Gottlieb CA, Clarke MF. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 1993; 13: 711-9.
24. Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature- sensitive mutant of p53. Cell 1990; 62: 671-80.
25. Yonish Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin 6. Nature 1991; 352: 345-7.
26. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
27. Vikhanskaya F, Erba E, D'Incalci M, Broggini M. Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogeneous p53. Nucleic Acids Res 1994; 22: 1012-7.
28. Tauchi H, Sawada S. Analysis of mitotic cell death caused by radiation in mouse leukemia L5178Y cells: apoptosis is the ultimate form of cell death following mitotic failure. Int J Radiat Biol 1994; 65: 449-55.